Conference
Olaparib plus paclitaxel plus carboplatin (P/C) followed by olaparib maintenance treatment in patients (pts) with platinum-sensitive recurrent serous ovarian cancer (PSR SOC): A randomized, open-label phase II study.
Authors
Oza AM; Cibula D; Oaknin A; Poole CJ; Mathijssen RHJ; Sonke GS; Colombo N; Spacek J; Vuylsteke P; Hirte HW
Volume
30
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
May 20, 2012
Name of conference
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
Chicago, IL
Conference start date
June 1, 2012
Conference end date
June 6, 2012
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X